Literature DB >> 6447455

Piperacillin therapy for serious bacterial infections.

D J Winston, W Murphy, L S Young, W L Hewitt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6447455     DOI： 10.1016/0002-9343(80)90386-1

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  30 in total

1.  Comparison of two antibiotic regimens (piperacillin plus amikacin versus ceftazidime plus amikacin) as empiric therapy for febrile neutropenic patients with cancer.

Authors:  J Feliu; A Artal; M González Barón; A Berrocal; I Chacón; M L García de Paredes; E Espinosa; A Ordóñez; P Zamora; J M Montero
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

2.  Prospective study of epidemiology and prognostic factors in community-acquired pneumonia.

Authors:  J Gómez; V Baños; J Ruiz Gómez; M C Soto; L Muñoz; M L Nuñez; M Canteras; M Valdés
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-07       Impact factor: 3.267

3.  Clinical comparison of piperacillin and cefoxitin in patients with bacteriologically confirmed infections.

Authors:  R V McCloskey
Journal:  Antimicrob Agents Chemother       Date:  1986-09       Impact factor: 5.191

Review 4.  Bacterial resistance: exploring the facts and myths.

Authors:  B R Meyers
Journal:  Bull N Y Acad Med       Date:  1987-04

5.  Efficacy, safety, and tolerance of piperacillin/tazobactam compared to co-amoxiclav plus an aminoglycoside in the treatment of severe pneumonia.

Authors:  R Speich; E Imhof; M Vogt; M Grossenbacher; W Zimmerli
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-05       Impact factor: 3.267

6.  Penetration of piperacillin into bronchial mucosa and sputum.

Authors:  G E Marlin; K R Burgess; J Burgoyne; G R Funnell; M D Guinness
Journal:  Thorax       Date:  1981-10       Impact factor: 9.139

7.  Imipenem antagonism of the in vitro activity of piperacillin against Pseudomonas aeruginosa.

Authors:  M A Bertram; L S Young
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

8.  Treatment of hospitalized patients with complicated skin and skin structure infections: double-blind, randomized, multicenter study of piperacillin-tazobactam versus ticarcillin-clavulanate. The Piperacillin/Tazobactam Skin and Skin Structure Study Group.

Authors:  J S Tan; R M Wishnow; D A Talan; F P Duncanson; C W Norden
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

9.  Clinical significance of anaerobic bacteremias in a general hospital. A prospective study from 1988 to 1992.

Authors:  J Gómez; V Baños; J Ruiz; F Herrero; M Pérez; L Pretel; M Canteras; M Valdés
Journal:  Clin Investig       Date:  1993-08

Review 10.  Penicillins. A current review of their clinical pharmacology and therapeutic use.

Authors:  Dilip Nathwani; Martin J Wood
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.